Company / Operating Cash Flow per Share
Edwards Lifesciences Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.75
FY2025
5-year range
$0.90 / $2.85
FY2021-FY2025
Trend
+204.5%
vs FY2024
Sector context
#76 of 161
Health Care
What the data says
Operating Cash Flow per Share changed +204% YoY in FY2025, a notable deviation from the 9-year average annual change of +23%.
Based on SEC 10-K filings.
2.75 in FY2025 with a 5-year CAGR of +10.2%.
Declined from $2.85 to $2.75 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +10.2%
- 10-Year CAGR
- -
Sector benchmark
#76 of 161 in Health CareTop 47% of 161This company $2.75 Sector average $6.67
▼
-58.8% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 204.5% year-over-year.
- Ranks #76 out of 161 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.75 | +204.5% |
| FY2024 | $0.90 | -68.3% |
| FY2023 | $2.85 | +42.2% |
| FY2022 | $2.00 | -27.8% |
| FY2021 | $2.78 | +64.3% |
| FY2020 | $1.69 | -70.1% |
| FY2019 | $5.66 | +26.8% |
| FY2018 | $4.46 | -5.7% |
| FY2017 | $4.73 | +42.1% |
| FY2016 | $3.33 | -34.7% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026